Australia

Avance Clinical Briefs 45 Korean Biotechs on Global Drug Development

Dt & SanoMedics Chairman, Charles Park (Park, Chae Gyoo) and Avance Clinical CEO Yvonne Lungershausen co-hosting the Global Clinical Trial Strategy...

 October 23, 2023 | News

Cameron Smith Appointed as Chief Business Development Officer for Agilex Biolabs

Cameron brings a wealth of experience in the Bioanalytical field, with a particular focus on Toxicology. His extensive knowledge and global market expertis...

 October 17, 2023 | News

Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio

 First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...

 October 13, 2023 | News

EQT's Acquisition: VetPartners, Key Animal Health Provider in Australia and New Zealand

EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty ...

 October 12, 2023 | News

CSL Inks Renewable Power Deal with AGL for Australian Manufacturing

The agreement will significantly advance CSL's Scope 1 & 2 emissions reductions with all electricity used by CSL's Australian manufacturing sites ...

 October 12, 2023 | News

Gencurix Receives Australian Government Approval for Droplex POLE Mutation Test

This test employs Droplet Digital PCP (ddPCR) technology to analyze POLE gene mutations in endometrial cancer patients, facilitating the detection of genet...

 October 12, 2023 | News

Monash University Sets Australian Standard with Groundbreaking Diabetes Precision Medicine Report.

In a significant development, a new international consensus report on precision medicine in diabetes prevention and care has been released in the renowned ...

 October 11, 2023 | News

Australia's First Cu-67 SAR-Bombesin Prostate Cancer Trial Patient Treated

  COMBAT, which derives from "Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and co...

 October 04, 2023 | News

Bionomics Reports Positive Phase 2b Results for BNC210 in Post-Traumatic Stress Disorder Trial

ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant reduction in total PTSD symptom severity at 12 weeks. St...

 September 29, 2023 | News

Advanced Cancer Imaging Tool Streamlines Radiotherapy Adjustment for Doctors

An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for patients receiving care a...

 September 29, 2023 | News

Actinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design

Changes to the XanaMIA protocol reduce cost by AUD 30 million over the next two years and speed time to initial results while preserving the 36-week design...

 September 27, 2023 | News

Australia Launches National Study on Back and Neck Pain Risk Factors

The University of Adelaide's Experts Lead Landmark Australian Study on Back and Neck Pain A team of experts from the University of Adelaide is spearheadin...

 September 18, 2023 | News

Asia Pacific Nations Grapple with Plummeting Fertility Rates and Environmental Crisis, Urgent Actions Needed

Societies around the world are being confronted by inexorable evidence of falling fertility rates and environmental collapse that pose major threats to hum...

 September 08, 2023 | News

"Advancing Precision Oncology: Dr. Jerome Boyd-Kirkup Discusses Breakthroughs in HMBD-001 Trials"

In this exclusive interview with Dr. Jerome Boyd-Kirkup, Chief Scientific Officer of Hummingbird Bioscience, BioPharma APAC  delve into the recently i...

 September 06, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close